Medtronic MiniMed Paradigm Insulin pump, model number MMT-722K
FDA Recall Z-1590-2020 · Posted 2020-03-26
Advertisement
Recalling FirmMedtronic MiniMed
Recall StatusOpen, Classified
Product CodeOYC
Date Initiated2019-06-27
Product Quantity17
Reason for Recall
The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Firm Action
On June 27, 2019, Medtronic issued an Urgent Field Safety Notification letter via mail and email to its consignees. Medtronic made the decision to renotify customers, and on January 4, 2023, Medtronic issued an Urgent Medical Device Correction - Update letter. The communication asks consignees to take the following actions:
.To find the software version for the MiniMed Paradigm pumps, go to the STATUS screen:
. To open the STATUS screen, press ESC until the STATUS screen appears.
. To view more text on the STATUS screen, press the up or down arrow to scroll and view all the information.
. To exit the STATUS screen, press ESC until the STATUS screen disappears.
ACTIONS REQUIRED:
1. Review and take the following cybersecurity precautions listed below.
2. Please complete and sign the customer confirmation form attached as indicated and return by mail using the attached prepaid envelope. You can also email this form to our Field Corrective Action Department at [email protected] or send via fax to 1-888-844-8084 to the attention of FCA Department.
Root Cause
Device Design
Distribution Pattern
US nationwide distribution including Puerto Rico.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement